BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 283 filers reported holding BLUEBIRD BIO INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $214,000 | -31.6% | 11,200 | +14.3% | 0.01% | -36.4% |
| Q2 2021 | $313,000 | -4.9% | 9,800 | +60.7% | 0.01% | -35.3% |
| Q3 2020 | $329,000 | -11.6% | 6,100 | 0.0% | 0.02% | -19.0% |
| Q2 2020 | $372,000 | +32.9% | 6,100 | 0.0% | 0.02% | +5.0% |
| Q1 2020 | $280,000 | -47.7% | 6,100 | 0.0% | 0.02% | -33.3% |
| Q4 2019 | $535,000 | +110.6% | 6,100 | +205.0% | 0.03% | +87.5% |
| Q2 2019 | $254,000 | -19.4% | 2,000 | 0.0% | 0.02% | -20.0% |
| Q1 2019 | $315,000 | +7.9% | 2,000 | 0.0% | 0.02% | +17.6% |
| Q3 2018 | $292,000 | -7.0% | 2,000 | 0.0% | 0.02% | -10.5% |
| Q2 2018 | $314,000 | -8.2% | 2,000 | 0.0% | 0.02% | -13.6% |
| Q1 2018 | $342,000 | -23.1% | 2,000 | -20.0% | 0.02% | -21.4% |
| Q4 2017 | $445,000 | +38.6% | 2,500 | -50.0% | 0.03% | -80.3% |
| Q4 2015 | $321,000 | – | 5,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 46,264 | $3,958,000 | 7.80% |
| RTW INVESTMENTS, LP | 151,594 | $12,969,000 | 4.03% |
| APIS CAPITAL ADVISORS, LLC | 30,870 | $2,640,000 | 3.65% |
| Parametrica Management Ltd | 4,084 | $349,000 | 2.20% |
| Eventide Asset Management | 419,600 | $35,897,000 | 2.09% |
| RA Capital Management | 167,367 | $14,318,000 | 2.06% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 483,000 | $41,321,000 | 1.60% |
| Taylor Wealth Management Partners | 38,184 | $3,267,000 | 1.58% |
| Orbimed Advisors | 1,188,900 | $101,710,000 | 1.03% |
| CABOT WEALTH MANAGEMENT INC | 34,195 | $2,925,000 | 0.81% |